Cargando…

Acquired thrombotic thrombocytopenic purpura after first vaccination dose of BNT162b2 mRNA COVID-19 vaccine

Detalles Bibliográficos
Autores principales:	Ruhe, Johannes, Schnetzke, Ulf, Kentouche, Karim, Prims, Florian, Baier, Michael, Herfurth, Konstantin, Schlosser, Mandy, Busch, Martin, Hochhaus, Andreas, Wolf, Gunter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311064/ https://www.ncbi.nlm.nih.gov/pubmed/34309715 http://dx.doi.org/10.1007/s00277-021-04584-y

Ejemplares similares

Immune-Mediated Thrombotic Thrombocytopenic Purpura after BNT162b2 Vaccine
por: Güney, Tekin, et al.
Publicado: (2022)

Thrombotic thrombocytopenic purpura: a new menace after COVID bnt162b2 vaccine
por: Waqar, Syed Hamza Bin, et al.
Publicado: (2021)

Vaccination and Thrombotic Thrombocytopenic Purpura
por: Yavaşoğlu, İrfan
Publicado: (2020)

BNT162b2 COVID-19 Vaccine Induced Immune Thrombocytopenic Purpura
por: Ghosh, A. K., et al.
Publicado: (2022)

Acquired Thrombotic Thrombocytopenic Purpura Following BNT162b2 mRNA Coronavirus Disease Vaccination in a Japanese Patient
por: Yoshida, Kikuaki, et al.
Publicado: (2021)

Thrombotic thrombocytopenic purpura
por: Knöbl, Paul
Publicado: (2018)

Therapierefraktäre thrombotisch-thrombozytopenische Purpura
por: Herfurth, K., et al.
Publicado: (2022)

Semi-selective plasma filtration applied to the treatment of acquired thrombotic thrombocytopenic purpura following bnt162b2 administration
por: Fenoglio, Roberta, et al.
Publicado: (2022)

Relapse of thrombotic thrombocytopenic purpura after COVID-19 vaccine
por: Sissa, Cinzia, et al.
Publicado: (2021)

Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry
por: Agosti, Pasquale, et al.
Publicado: (2023)

Immune-Mediated Thrombotic Thrombocytopenic Purpura Following mRNA-Based COVID-19 Vaccine BNT162b2: Case Report and Mini-Review of the Literature
por: Buetler, Vanessa Alexandra, et al.
Publicado: (2022)

Thrombotic Thrombocytopenic Purpura and Gemcitabine
por: Kasi, Pashtoon Murtaza
Publicado: (2011)

Dengue and Thrombotic Thrombocytopenic Purpura
por: Wiwanitkit, Viroj
Publicado: (2017)

Caplacizumab for thrombotic thrombocytopenic purpura
Publicado: (2020)

Hereditary Thrombotic Thrombocytopenic Purpura
por: Nusrat, Sanober, et al.
Publicado: (2023)

Hemostatic Markers, Adamts-13 Profile and Anti-Sars-Cov-2 Antibody Levels in Patients with Immune Thrombotic Thrombocytopenic Purpura Receiving BNT162b2 Vaccination
por: Schieppati, Francesca, et al.
Publicado: (2021)

Erratum: Immune-mediated thrombotic thrombocytopenic purpura following mRNA-based COVID-19 vaccine BNT162b2: Case report and mini-review of the literature
Publicado: (2023)

SARS-CoV-2 vaccination and immune thrombotic thrombocytopenic purpura
por: Shah, Hridaya, et al.
Publicado: (2022)

Acquired thrombotic thrombocytopenic purpura following Pfizer COVID‐19 vaccination
por: Alislambouli, Mawaddah, et al.
Publicado: (2021)

Thrombotic Thrombocytopenic Purpura after Ad26.COV2-S Vaccination
por: Yocum, Andrew, et al.
Publicado: (2021)

Immune-mediated thrombotic thrombocytopenic purpura following COVID-19 vaccination
por: Picod, Adrien, et al.
Publicado: (2022)

Thrombotic Thrombocytopenic Purpura After Ad6.COV2.S Vaccination
por: Ramanan, Sruthi, et al.
Publicado: (2022)

Recurrence of Thrombotic Thrombocytopenic Purpura After COVID-19 Vaccination: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Thrombotic Thrombocytopenic Purpura Associated with Pazopanib
por: Syed, Umer, et al.
Publicado: (2018)

Novel therapies in thrombotic thrombocytopenic purpura
por: Masias, Camila, et al.
Publicado: (2017)

Thrombotic Thrombocytopenic Purpura Associated with Dermatomyositis
por: Malik, Zohra R, et al.
Publicado: (2018)

Cardiac implications of thrombotic thrombocytopenic purpura
por: Wiernek, Szymon L, et al.
Publicado: (2018)

Ticagrelor-associated thrombotic thrombocytopenic purpura
por: Doğan, Ali, et al.
Publicado: (2017)

Valacyclovir-Induced Thrombotic Thrombocytopenic Purpura
por: Bukhari, Sumera, et al.
Publicado: (2020)

Thrombotic thrombocytopenic purpura secondary to Streptococcus
por: Morrin, M.J., et al.
Publicado: (2006)

Hydroxychloroquine-Associated Thrombotic Thrombocytopenic Purpura
por: Arıkan, Fatma, et al.
Publicado: (2020)

Caplacizumab for Acute Thrombotic Thrombocytopenic Purpura
por: Katsivalis, Katherine V., et al.
Publicado: (2021)

Daratumumab for immune thrombotic thrombocytopenic purpura
por: van den Berg, Jana, et al.
Publicado: (2022)

A Case of Idiopathic Thrombocytopenic Purpura After Booster Dose of BNT162b2 (Pfizer-Biontech) COVID-19 Vaccine
por: Malayala, Srikrishna V, et al.
Publicado: (2021)

Thrombotic Thrombocytopenic Purpura Presentation in an Elderly Gentleman Following COVID Vaccine Circumstances
por: Chamarti, Karthik, et al.
Publicado: (2021)

Covid-19-vaccine-pfizer-biontech: Thrombotic thrombocytopenic purpura: case report
Publicado: (2021)

Thrombotic thrombocytopenic purpura after vaccination for COVID-19: lesson for the clinical nephrologist
por: Özcan, Fedai, et al.
Publicado: (2022)

Relapse of Immune Thrombotic Thrombocytopenic Purpura Following Vaccination with COVID19 mRNA Vaccine
por: Pavenski, Katerina
Publicado: (2021)

Recurrence of Thrombotic Thrombocytopenic Purpura After Vaccination with mRNA-1273 COVID-19 vaccine
por: Ntelis, Spyridon, et al.
Publicado: (2022)

Opana-induced thrombotic microangiopathy masquerading as thrombotic thrombocytopenic purpura
por: Ban, Byung H., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1jlhqqk58093m53e3mtb4c731u